Results 1 to 10 of about 6,451 (213)

Paracoccidioidomycosis with sarcoid-like cutaneous lesion: A clinicopathological challenge

open access: yesIDCases, 2022
We describe a case of sarcoid-like cutaneous paracoccidioidomycosis in a 26-year-old male, with a 10-year evolution, wrongly diagnosed as granulomatous rosacea. The correct diagnosis was only possible after the appearance of a new skin lesion with a more
Cristiane Botelho Miranda Cárcano   +4 more
doaj   +2 more sources

Paracoccidioidomycosis Diagnosed in Europe—A Systematic Literature Review

open access: yesJournal of Fungi (Basel, Switzerland), 2021
Paracoccidioidomycosis is a systemic mycosis that is endemic in geographical regions of Central and South America. Cases that occur in nonendemic regions of the world are imported through migration and travel. Due to the limited number of cases in Europe,
Gernot Wagner   +2 more
exaly   +2 more sources

Paracoccidioidomycosis Protective Immunity

open access: yesJournal of Fungi (Basel, Switzerland), 2021
Protective immunity against Paracoccidioides consists of a stepwise activation of numerous effector mechanisms that comprise many cellular and soluble components.
Eva Burger
exaly   +2 more sources

Clinical and Eco-Epidemiological Aspects of a Novel Hyperendemic Area of Paracoccidioidomycosis in the Tocantins-Araguaia Basin (Northern Brazil), Caused by Paracoccidioides sp.

open access: yesJournal of Fungi, 2022
Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Brazil. The disease is caused by dimorphic fungi nested within the Paracoccidioides genus.
Alessandra G. Krakhecke-Teixeira   +10 more
doaj   +2 more sources

New Trends in Paracoccidioidomycosis Epidemiology

open access: yesJournal of Fungi (Basel, Switzerland), 2017
Paracoccidioidomycosis is a systemic fungal disease occurring in Latin America and more prevalent in South America. The disease is caused by the dimorphic fungus Paracoccidioides spp. whose major hosts are humans and armadillos.
Roberto MartÍnez
exaly   +2 more sources

Paracoccidioidomycosis: an update [PDF]

open access: yesClinical Microbiology Reviews, 1993
This review summarizes knowledge on various aspects of paracoccidioidomycosis. Mycelial propagules, chlamydospores, and arthroconidia exhibit thermal dimorphism; arthroconidia are infectious in animals and, by electron microscopy, appear well provided for survival. The mycelial-to-yeast-phase transformation requires a strict control of glucan synthesis
Elizabeth Castañeda
exaly   +4 more sources

Metabolomics and Machine Learning Approaches Combined in Pursuit for More Accurate Paracoccidioidomycosis Diagnoses

open access: yesmSystems, 2020
Brazil and many other Latin American countries are areas of endemicity for different neglected diseases, and the fungal infection paracoccidioidomycosis (PCM) is one of them. Among the clinical manifestations, pneumopathy associated with skin and mucosal
Estela de Oliveira Lima   +12 more
doaj   +2 more sources

EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2015
SUMMARYThe epidemiological characteristics of paracoccidioidomycosis were reviewed and updated. The new endemic areas in Brazil were discussed in the section regarding the geographic distribution of the mycosis.
Roberto MARTINEZ
doaj   +4 more sources

Treatment compliance of patients with paracoccidioidomycosis in Central-West Brazil

open access: yesJornal Brasileiro de Pneumologia, 2019
Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to ...
Ursulla Vilella Andrade   +7 more
doaj   +2 more sources

Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review

open access: yesJournal of Fungi, 2018
Paracoccidioidomycosis (PCM) is an endemic mycosis found in Latin America that causes systemic disease mostly in immunocompetent hosts. A small percentage of PCM occurs in immunocompromised patients where low clinical suspicion of the infection, late ...
João N. de Almeida   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy